USA In 2025, just 318 US biotech deals closed in Q2 – the lowest in a decade – even as mega-rounds propped up total investment volumes. For a sector that was booming during the pandemic era, the contrast could not be starker. Leaders from trade organisations and innovation accelerators agree on…
USA Jennifer Hawks Bland, CEO of NewYorkBIO, discusses the rapid growth and transformation of New York’s life sciences ecosystem, emphasizing the importance of policy advocacy, capital formation, and access to innovation. As New York continues to build a strong foundation for biopharma and biotech, Hawks Bland highlights how the organization is…
USA Although Boston and California may be more internationally renowned as biotech hubs, New York is fast catching up. Thanks in large part to its strong scientific and business infrastructure and easy access to capital, growing numbers of early-stage biotechs are choosing to base their operations in New York and list…
USA Jennifer Hawks Bland of NewYorkBIO, the premier trade association for the life sciences in New York State, discusses the association’s diverse list of members, the services it provides them, and how New York is building a bio-ecosystem to rival those of Boston and California. We have the unique ability…
See our Cookie Privacy Policy Here
